PATENT CLAIM ANALYSIS

Application Number: 16253026
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "423000"]

Abstract:
Disclosed are various bioactive and/or biocompatible materials and methods of making the same.

Claim (Index 13):
The method of  claim 12 , wherein the one or more intracellular growth factors are selected from the group consisting of: a bone morphogenetic protein, a transforming growth factor beta, a growth differentiation factor, a cartilage derived morphogenetic protein, an interleukin, an interferon, a lymphokine, a chemokine, a platelet derived growth factor, a vascular endothelial growth factor, a fibroblast growth factor, and combinations thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15654830', '15525418', '15016072', '14880675', '13458286']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.759612685308381
- 35 USC 102 Novelty (BERT): 0.5294784111551591
- Combined Prediction Score: 0.7365992578930588
- Mean Citation Score: 245.96051799999995
- Max Citation Score: 355.55643
- Similarity Product: 239.39621779872715

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test